Page 91 - MDAnderson Memoria 2017

91
LISTADO DE PUBLICACIONES
Papers published
ANATOMÍA PATOLÓGICA Y LABORATORIO DE INVESTIGACIÓN TRASLACIONAL
ANATOMIC PATHOLOGY AND TRANSLATIONAL RESEARCH LABORATORY
• Campos-Martín Y, Martínez N, Martínez-López A, Cereceda L, Casado F, Algara P, Oscier D, Menarguez FJ, García JF, Piris MA, Mollejo M. Clinical and diagnostic relevance of NOTCH2 and KLF2 mutations in splenic marginal zone lymphoma. Haematologica. 2017; 102(8):e310-e312. PMID: 28522570. PMCID: PMC5541884.
• Carreras J, Kikuti YY, Beà S, Miyaoka M, Hiraiwa S, Ikoma H, Nagao R, Tomita S, Martin-García D, Salaverria I, Sato A, Ichiki A, Roncador G, García JF, Ando K, Campo E, Nakamura N. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS). Histopathology. 2017 Mar;70(4):595-621. doi: 10.1111/his.13106. 2017 Jan 9. PMID: 27775850.
• Franco F, González-Rincón J, Lavernia J, García JF, Martín P, Bellas C, Piris MA, Pedrosa L, Miramón J, Gómez-Codina J, Rodríguez-Abreu D, Machado I, Illueca C, Alfaro J, Provencio M, Sánchez-Beato M. Mutational profile of primary breast diffuse large B-cell lymphoma. Oncotarget. 2017; 8(61):102888-102897. PMID: 29262531, PMCID: PMC5732697
• Mata E, Díaz-López A, Martín-Moreno AM, Sánchez-Beato M, Varela I, Mestre MJ, Santonja C, Burgos F, Menárguez J, Estévez M, Provencio M, Sánchez-Espiridión B, Díaz E, Montalbán C, Piris MA, García JF. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. Oncotarget. 2017; 8(67):111386-111395. PMID: 29340061, PMCID: PMC5762329 van der Putten LJ,
• van de Vijver K, Bartosch C, Davidson B, Gatius S, Matias-Guiu X, McCluggage WG, Toledo G, van der Wurff AA, Pijnenborg JM, Massuger LF, Bulten J. Reproducibility of measurement of myometrial invasion in endometrial carcinoma. Virchows Arch. 2017 Jan;470(1):63-68. doi: 10.1007/s00428-016-2035-5. 2016 Oct 27. PMID: 27787595
• Gatius S, Cuevas D, Fernández C, Roman-Canal B, Adamoli V, Piulats JM, Eritja N, Martin-Satue M, Moreno-Bueno G, Matias-Guiu X. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences. Pathobiology. 2017 Jun 15. doi: 10.1159/000475529. PMID: 28614814.
• Santamaria PG, Moreno-Bueno G, Portillo F, Cano A. EMT: Present and future in clinical oncology. Mol Oncol. 2017 Jun 7. doi: 10.1002/1878-0261.12091. Review. PMID: 28590039.
• Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Castellà E, Nellist M, Morales S, Valls J, Velasco A, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EEW, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M, Cortés J, Lázaro C, Odero MD, Martens JWM, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. 2016 Dec 19. PMID: 27991928; PMCID: PMC5442428.
• García-Sanz P, Triviño JC, Mota A, Pérez López M, Colás E, Rojo-Sebastián A, García Á, Gatius S, Ruiz M, Prat J, López-López R, Abal M, Gil-Moreno A, Reventós J, Matias-Guiu X, Moreno-Bueno G. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma. Int J Cancer. 2017 Apr 1;140(7):1551-1563. doi: 10.1002/ijc.30573. doi: 10.1002/ijc.30573. PMID: 27997699.
• Cuevas EP, Eraso P, Mazón MJ, Santos V, Moreno-Bueno G, Cano A, Portillo F. LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway. Sci Rep. 2017 Mar 23;7:44988. doi: 10.1038/srep44988. PMID: 28332555; PMCID: PMC5362953.
•Devis L, Moiola CP, Masia N, Martínez-García E, Santacana M, Stirbat TV, Brochard-Wyart F, García Á, Alameda F, Cabrera S, Palacios J, Moreno-Bueno G, Abal M, Thomas W, Dufour S, Matias-Guiu X, Santamaría A, Reventos J, Gil-Moreno A, Colas E. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer. J Pathol. 2017 Mar;241(4):475-487. doi: 10.1002/path.4851. 2017 Jan 23. PMID: 27873306.